2-[(1S)-1-hydroxyethyl]-3-(4-methylpiperazin-1-yl)quinazolin-4-one | 633305-70-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 2-[(1S)-1-hydroxyethyl]-3-(4-methylpiperazin-1-yl)quinazolin-4-one
• CAS: 633305-70-1
• 化学式: C₁₅H₂₀N₄O₂
• 分子量: 288.349
• InChiKey: XVOIIFBBGXNKEI-NSHDSACASA-N

物化性质

• 沸点：
  446.1±55.0 °C(Predicted)
• 密度：
  1.31±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  21
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  59.4
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-[(1S)-1-hydroxyethyl]-3-(4-methylpiperazin-1-yl)quinazolin-4-one 在 偶氮二甲酸二异丙酯 、 巯基乙酸 、 三乙胺 、 三苯基膦 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 生成 3-(3-chlorophenyl)-1-(2,4-dimethoxyphenyl)-1-[(1R)-1-[3-(4-methylpiperazin-1-yl)-4-oxoquinazolin-2-yl]ethyl]urea
  参考文献：
  名称：

  Quinazolinone-based fungal efflux pump inhibitors. Part 1: Discovery of an (N-methylpiperazine)-containing derivative with activity in clinically relevant Candida spp.

  摘要：

  The discovery of a series of quinazolinone-based fungal efflux pump inhibitors by high-throughput screening for potentiation of fluconazole in C. albicans is described. Attempts to improve the aqueous solubility of screening hits led to the discovery of an analog with greatly improved physical properties and activity against clinically-relevant Candida spp. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.07.070
• 作为产物：
  描述：

  [(1S)-1-(4-oxo-3,1-benzoxazin-2-yl)ethyl] acetate 在 水 、 溶剂黄146 、 三乙胺 作用下， 以 甲醇 为溶剂， 生成 2-[(1S)-1-hydroxyethyl]-3-(4-methylpiperazin-1-yl)quinazolin-4-one
  参考文献：
  名称：

  Quinazolinone-based fungal efflux pump inhibitors. Part 1: Discovery of an (N-methylpiperazine)-containing derivative with activity in clinically relevant Candida spp.

  摘要：

  The discovery of a series of quinazolinone-based fungal efflux pump inhibitors by high-throughput screening for potentiation of fluconazole in C. albicans is described. Attempts to improve the aqueous solubility of screening hits led to the discovery of an analog with greatly improved physical properties and activity against clinically-relevant Candida spp. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.07.070

文献信息

• Fungal efflux pump inhibitors
  申请人：——

  公开号：US20030229097A1

  公开（公告）日：2003-12-11

  This invention relates to compounds that are efflux pump inhibitors and therefore are useful as potentiators of anti-fungal agents for the treatment of infections caused by fungi that employ an efflux pump resistance mechanism.

  这项发明涉及一种能够抑制外排泵并因此可用作抗真菌药物的增效剂，用于治疗由利用外排泵耐药机制的真菌引起的感染。
• Quinazolinone-based fungal efflux pump inhibitors. Part 1: Discovery of an (N-methylpiperazine)-containing derivative with activity in clinically relevant Candida spp.
  作者：Rémy C. Lemoine、Tomasz W. Glinka、William J. Watkins、Aesop Cho、Jessie Yang、Nadeem Iqbal、Rajeshwar Singh、Deidre Madsen、Karen Lolans、Olga Lomovskaya、Uma Oza、Michael N. Dudley

  DOI：10.1016/j.bmcl.2004.07.070

  日期：2004.10

  The discovery of a series of quinazolinone-based fungal efflux pump inhibitors by high-throughput screening for potentiation of fluconazole in C. albicans is described. Attempts to improve the aqueous solubility of screening hits led to the discovery of an analog with greatly improved physical properties and activity against clinically-relevant Candida spp. (C) 2004 Elsevier Ltd. All rights reserved.